tradingkey.logo

ASP Isotopes Inc

ASPI
9.150USD
-0.980-9.67%
Cierre 11/03, 16:00ETCotizaciones retrasadas 15 min
767.73MCap. mercado
PérdidaP/E TTM

ASP Isotopes Inc

9.150
-0.980-9.67%

Más Datos de ASP Isotopes Inc Compañía

ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.

Información de ASP Isotopes Inc

Símbolo de cotizaciónASPI
Nombre de la empresaASP Isotopes Inc
Fecha de salida a bolsaNov 10, 2022
Director ejecutivoMr. Paul Elliot Mann
Número de empleados136
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 10
Dirección601 Pennsylvania Avenue Nw
CiudadWASHINGTON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal20004
Teléfono12027562245
Sitio Webhttps://aspisotopes.com/
Símbolo de cotizaciónASPI
Fecha de salida a bolsaNov 10, 2022
Director ejecutivoMr. Paul Elliot Mann

Ejecutivos de ASP Isotopes Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul Elliot Mann
Mr. Paul Elliot Mann
Executive Chairman of the Board
Executive Chairman of the Board
8.08M
+10.51%
Dr. Hendrik Strydom, Ph.D.
Dr. Hendrik Strydom, Ph.D.
Chief Technology Officer
Chief Technology Officer
2.30M
-2.39%
Mr. Robert Ainscow
Mr. Robert Ainscow
Interim Chief Executive Officer (Principal Executive Officer), Co-Founder, Chief Operating Officer
Interim Chief Executive Officer (Principal Executive Officer), Co-Founder, Chief Operating Officer
1.65M
-1.35%
Dr. Duncan Moore, Ph.D.
Dr. Duncan Moore, Ph.D.
Independent Director
Independent Director
994.55K
-7.01%
Ms. Heather Kiessling
Ms. Heather Kiessling
Chief Financial Officer
Chief Financial Officer
812.50K
+96.97%
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
710.23K
--
Prof. Michael (Mike) Gorley, Ph.D.
Prof. Michael (Mike) Gorley, Ph.D.
Independent Director
Independent Director
81.36K
-44.03%
Mr. Sipho Nkosinathi Maseko
Mr. Sipho Nkosinathi Maseko
Independent Director
Independent Director
22.42K
--
Ralph Hunter
Ralph Hunter
Independent Director
Independent Director
--
--
Mr. Robert Ryan
Mr. Robert Ryan
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul Elliot Mann
Mr. Paul Elliot Mann
Executive Chairman of the Board
Executive Chairman of the Board
8.08M
+10.51%
Dr. Hendrik Strydom, Ph.D.
Dr. Hendrik Strydom, Ph.D.
Chief Technology Officer
Chief Technology Officer
2.30M
-2.39%
Mr. Robert Ainscow
Mr. Robert Ainscow
Interim Chief Executive Officer (Principal Executive Officer), Co-Founder, Chief Operating Officer
Interim Chief Executive Officer (Principal Executive Officer), Co-Founder, Chief Operating Officer
1.65M
-1.35%
Dr. Duncan Moore, Ph.D.
Dr. Duncan Moore, Ph.D.
Independent Director
Independent Director
994.55K
-7.01%
Ms. Heather Kiessling
Ms. Heather Kiessling
Chief Financial Officer
Chief Financial Officer
812.50K
+96.97%
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
710.23K
--

Desglose de ingresos

Sin datos
Sin datos
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: lun., 29 de sep
Actualizado: lun., 29 de sep
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Mann (Paul Elliot)
7.31%
AK Jensen Investment Management Ltd
4.26%
Alyeska Investment Group, L.P.
3.78%
AWM Investment Company, Inc.
3.56%
Vasnetsov Sergey
3.47%
Otro
77.62%
Accionistas
Accionistas
Proporción
Mann (Paul Elliot)
7.31%
AK Jensen Investment Management Ltd
4.26%
Alyeska Investment Group, L.P.
3.78%
AWM Investment Company, Inc.
3.56%
Vasnetsov Sergey
3.47%
Otro
77.62%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
21.74%
Individual Investor
15.20%
Investment Advisor/Hedge Fund
9.44%
Hedge Fund
7.59%
Corporation
4.26%
Research Firm
1.73%
Pension Fund
0.19%
Bank and Trust
0.13%
Insurance Company
0.05%
Otro
39.67%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
223
45.23M
40.91%
+6.04M
2025Q2
193
58.14M
63.48%
+2.82M
2025Q1
180
54.35M
73.22%
-5.67M

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Mann (Paul Elliot)
8.08M
8.8%
+768.74K
+10.51%
Sep 09, 2025
AK Jensen Investment Management Ltd
4.71M
5.12%
-875.06K
-15.67%
Dec 31, 2024
Alyeska Investment Group, L.P.
4.18M
4.55%
+4.18M
--
Jun 30, 2025
AWM Investment Company, Inc.
3.93M
4.28%
-580.00K
-12.86%
Jun 30, 2025
Vasnetsov Sergey
3.84M
4.18%
--
--
Apr 29, 2025
BlackRock Institutional Trust Company, N.A.
3.68M
4.01%
-97.51K
-2.58%
Jun 30, 2025
The Vanguard Group, Inc.
3.28M
3.56%
+187.69K
+6.08%
Jun 30, 2025
Capital Research Global Investors
2.87M
3.12%
--
--
Jun 30, 2025
Philadelphia Financial Management of San Francisco, LLC
2.67M
2.91%
-837.85K
-23.88%
Jun 30, 2025
Rovida Investment Management Ltd
2.20M
2.39%
+1.85M
+528.57%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
Range Nuclear Renaissance Index ETF
3.99%
Invesco Dorsey Wright Basic Materials Momentum ETF
1.79%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.35%
iShares Micro-Cap ETF
0.16%
Vanguard US Momentum Factor ETF
0.15%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.07%
iShares Russell 2000 Growth ETF
0.04%
ProShares Hedge Replication ETF
0.03%
ProShares UltraPro Russell2000
0.03%
Schwab U.S. Small-Cap ETF
0.02%
Ver más
Range Nuclear Renaissance Index ETF
Proporción3.99%
Invesco Dorsey Wright Basic Materials Momentum ETF
Proporción1.79%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proporción0.35%
iShares Micro-Cap ETF
Proporción0.16%
Vanguard US Momentum Factor ETF
Proporción0.15%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.07%
iShares Russell 2000 Growth ETF
Proporción0.04%
ProShares Hedge Replication ETF
Proporción0.03%
ProShares UltraPro Russell2000
Proporción0.03%
Schwab U.S. Small-Cap ETF
Proporción0.02%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI